Article
Hepatic Toll-Like Receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin.
Journal of viral hepatitis - 1 Feb 2010
Yuki N, Matsumoto S, Kato M, Yamaguchi T
Abstract excerpt
Recent studies have shown that enhanced hepatic expression of several innate immune genes predicts non-response to 48 weeks of peginterferon plus ribavirin in chronic hepatitis C genotype 1. This study aimed to further address how gene expression of TLR3/RIG-I signalling correlates with the outcome of the 72-week extended treatment regimen. Relative hepatic mRNA expression and copy numbers of positive- and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
